Workshop
line
MIT logo
June 27-29, 2017 • MIT, Cambridge, MA
ucl
 

Agenda Day 2: Wednesday, June 28
Workshop schedule as of 3.23.17 – sessions, times, and speakers are subject to change.

line
  Time Event
line
  8:30 – 9:00 AM Continental Breakfast
line
  9:00 – 10:00 AM NUTS: The Challenge of Technical Life Cycle Management view abstract
Alain Pralong view bio
Chief Executive Officer, Pharma-Consulting ENABLE GmbH
line
  10:00 – 11:00 AM Conjugate Vaccines: Manufacturing and Development Challenges view abstract
Stephen A. Kolodziej view bio
Associate Research Fellow-Group Leader, Pfizer, Inc.
line
  11:00 – 11:30 AM Break
line
  11:30 AM – 12:30 PM A Well-Characterized Vaccine: A Case Study with GARDASIL® view abstract
Robert Sitrin
view bio
Senior Scientist Process Development, PATH
line
  12:30 – 1:30 PM Lunch
line
  1:30 – 2:30 PM Bioprocessing for Vaccine Viruses and Vectors view abstract
John Aunins
view bio
Executive Vice President of Bioprocess & Manufacturing and the Chief Technology Officer,
Seres Therapeutics, Inc.
line
  2:30 – 3:30 PM Quality Control of Human Viral Vaccines: Reducing the Risk of Viral and Microbial Contamination view abstract
Martin Wisher
view bio
Head of Regulatory Affairs,
BioReliance
line
  3:30 – 4:00 PM Break
line
  4:00 – 5:00 PM Innovative USP/DSP Approaches Applied to Viral Vaccines view abstract
José Castillo
view bio
Co-Founder and Chief Technology Officer, Univercells
line
  5:00 – 6:30 PM Influenza Vaccine Development and Manufacture (Case Study: Seasonal Strain Selection and Vaccine Supply Impact) view abstract
Matthew Downham
view bio
Associate Director, AstraZeneca
line
  6:30 – 7:30 PM Networking Reception
line
  Agenda Day 1 Agenda Day 2 Agenda Day 3      
Images
MIT CBI
BioMAN